Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/303% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Artivion free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Artivion's free cash flow for the twelve months ending Jun 30, 2026 was -$9.16M, down 219.5% year over year. For fiscal 2025 it was $839.00K, down 92.4% from the year before. Over ten years it grew -20.1% a year on average. The highest annual figure on record is $18.72M in fiscal 2010.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $839.00K | -92.4% |
| FY2024 | Dec 31, 2024 | $11.05M | +21.8% |
| FY2023 | Dec 31, 2023 | $9.07M | – |
| FY2022 | Dec 31, 2022 | -$15.87M | – |
| FY2021 | Dec 31, 2021 | -$15.68M | -411.0% |
| FY2020 | Dec 31, 2020 | $5.04M | -35.0% |
| FY2019 | Dec 31, 2019 | $7.76M | +89.4% |
| FY2018 | Dec 31, 2018 | $4.10M | -1.8% |
| FY2017 | Dec 31, 2017 | $4.17M | -69.2% |
| FY2016 | Dec 31, 2016 | $13.52M | +70.0% |
| FY2015 | Dec 31, 2015 | $7.95M | +108.8% |
| FY2014 | Dec 31, 2014 | $3.81M | -69.4% |
| FY2013 | Dec 31, 2013 | $12.43M | -21.9% |
| FY2012 | Dec 31, 2012 | $15.92M | +12.0% |
| FY2011 | Dec 31, 2011 | $14.21M | -24.1% |
| FY2010 | Dec 31, 2010 | $18.72M | +25.8% |
| FY2009 | Dec 31, 2009 | $14.88M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.01M | -202.5% |
| Q1 FY2026 | Mar 31, 2026 | -$6.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.95M | -191.2% |
| Q3 FY2025 | Sep 30, 2025 | $17.65M | +125.9% |
| Q2 FY2025 | Jun 30, 2025 | $11.72M | +223.7% |
| Q1 FY2025 | Mar 31, 2025 | -$20.59M | – |
| Q4 FY2024 | Dec 31, 2024 | $8.71M | +6.7% |
| Q3 FY2024 | Sep 30, 2024 | $7.82M | +51.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.62M | -23.5% |
| Q1 FY2024 | Mar 31, 2024 | -$9.10M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.17M | – |
| Q3 FY2023 | Sep 30, 2023 | $5.16M | +366.5% |
| Q2 FY2023 | Jun 30, 2023 | $4.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.00M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.01M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.84M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.85M | -156.2% |
| Q3 FY2021 | Sep 30, 2021 | -$6.18M | -198.4% |
| Q2 FY2021 | Jun 30, 2021 | -$3.10M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.54M | -4830.2% |
| Q4 FY2020 | Dec 31, 2020 | $3.29M | – |
| Q3 FY2020 | Sep 30, 2020 | $6.28M | -42.8% |
| Q2 FY2020 | Jun 30, 2020 | -$4.63M | – |
| Q1 FY2020 | Mar 31, 2020 | $96.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.79M | -119.9% |
| Q3 FY2019 | Sep 30, 2019 | $10.98M | +48.4% |
| Q2 FY2019 | Jun 30, 2019 | -$1.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$33.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $9.01M | +90.5% |
| Q3 FY2018 | Sep 30, 2018 | $7.40M | +321.5% |
| Q2 FY2018 | Jun 30, 2018 | -$470.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.84M | -745.4% |
| Q4 FY2017 | Dec 31, 2017 | $4.73M | +100.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.76M | -74.7% |
| Q2 FY2017 | Jun 30, 2017 | -$4.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.36M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.93M | – |
See a number that looks wrong?